JAMES C BLAIR Insider Trading $PHRM PHARMION CORP
Get free email notifications about insider trading for JAMES C BLAIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES C BLAIR. JAMES C BLAIR is 10% Owner in SENOMYX INC ($SNMX) and 10% Owner in INTRALASE CORP ($ILSE) and 10% Owner in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in Paratek Pharmaceuticals, Inc. ($PRTK) and Director in PHARMION CORP ($PHRM) and 10% Owner in SANTARUS INC ($SNTS) and Director in NUVASIVE INC ($NUVA) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM) and 10% Owner in Northstar Neuroscience, Inc. ($NSTR) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and Director in CADENCE PHARMACEUTICALS INC ($CADX) and 10% Owner in SENORX INC ($SENO) and Director in aTYR PHARMA INC ($LIFE) and 10% Owner in Pernix Sleep, Inc. ($SOMX) and 10% Owner in INTERCELL USA, INC. ($IOMI) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in Volcano Corp ($VOLC) and Director in Volcano Corp ($VOLC) and Director in ZOGENIX, INC. ($ZGNX) and 10% Owner in VERACYTE, INC. ($VCYT) and 10% Owner in Orexigen Therapeutics, Inc. ($OREX) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in Evoke Pharma Inc ($EVOK) and 10% Owner in Esperion Therapeutics, Inc. ($ESPR) and 10% Owner in TANDEM DIABETES CARE INC ($TNDM) and Director in Clovis Oncology, Inc. ($CLVS) and 10% Owner in REVA Medical, Inc. ($RVA) and 10% Owner in Durata Therapeutics, Inc. ($DRTX).
JAMES C BLAIR in PHARMION CORP
Trading Symbol: PHRMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES C BLAIR: Director
Holdings: 0 shares
Latest Transaction: Mar 19 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES C BLAIR in PHARMION CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ACHN, ALIM, LIFE, CADX, CLVS, DRNA, DRTX, ESPR, EVOK, IOMI, ILSE, NSTR, NUVA, TZYM, OREX, PRTK, SOMX, PHRM, RVA, SNTS, SNMX, SENO, TNDM, TBRA, VNDA, VCYT, VOLC, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 31.27 | 7,500 | 234,525 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 18.65 | 7,500 | 139,875 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 20.33 | 5,000 | 101,650 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | D | 38.98 | 5,000 | 194,900 | 0 | |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 25,066 | 0 | 0 | 25.1 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,206 | 0 | 0 | 1.2 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 15,900 | 0 | 0 | 15.9 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 1,484,100 | 0 | 0 | 1.5 M to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 9,155 | 0 | 0 | 9.2 K to 0 (-100.00 %) |
Mar 19 2008 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 800,708 | 0 | 0 | 800.7 K to 0 (-100.00 %) |
Jun 08 2007 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | A | 31.27 | 7,500 | 234,525 | 7,500 | |
Jun 14 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.14 | 1,520 | 26,053 | 15,900 | 14.4 K to 15.9 K (+10.57 %) |
Jun 14 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.14 | 141,880 | 2,431,823 | 1,484,100 | 1.3 M to 1.5 M (+10.57 %) |
Jun 14 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.34 | 3,445 | 59,736 | 14,380 | 10.9 K to 14.4 K (+31.50 %) |
Jun 14 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.34 | 321,555 | 5,575,764 | 1,342,220 | 1 M to 1.3 M (+31.50 %) |
Jun 13 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.71 | 335 | 5,933 | 10,935 | 10.6 K to 10.9 K (+3.16 %) |
Jun 13 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 17.71 | 31,265 | 553,703 | 1,020,665 | 989.4 K to 1 M (+3.16 %) |
Jun 09 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | A | 18.65 | 7,500 | 139,875 | 7,500 | |
May 05 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 19.98 | 3,023 | 60,400 | 10,600 | 7.6 K to 10.6 K (+39.90 %) |
May 05 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 19.98 | 282,177 | 5,637,896 | 989,400 | 707.2 K to 989.4 K (+39.90 %) |
May 05 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 18.64 | 5,300 | 98,792 | 7,577 | 2.3 K to 7.6 K (+232.76 %) |
May 05 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 18.64 | 494,700 | 9,221,208 | 707,223 | 212.5 K to 707.2 K (+232.77 %) |
May 04 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 19.01 | 1,092 | 20,759 | 2,277 | 1.2 K to 2.3 K (+92.15 %) |
May 04 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | P | 19.01 | 101,908 | 1,937,271 | 212,523 | 110.6 K to 212.5 K (+92.13 %) |
May 02 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | P | 19.03 | 1,185 | 22,551 | 1,185 | 2.4 K to 1.2 K (-50.00 %) |
May 02 2006 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | P | 19.03 | 110,615 | 2,105,003 | 110,615 | 221.2 K to 110.6 K (-50.00 %) |
Jun 01 2005 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | A | 20.33 | 5,000 | 101,650 | 5,000 | |
Feb 17 2005 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | J | 0.00 | 25,066 | 0 | 25,066 | 0 to 25.1 K |
Feb 17 2005 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 85,775 | 0 | 0 | 85.8 K to 0 (-100.00 %) |
Feb 17 2005 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 31,250 | 0 | 0 | 31.3 K to 0 (-100.00 %) |
Nov 12 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | S | 50.19 | 10,205 | 512,189 | 9,155 | 19.4 K to 9.2 K (-52.71 %) |
Nov 12 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | S | 50.19 | 10,205 | 512,189 | 9,155 | 19.4 K to 9.2 K (-52.71 %) |
Oct 26 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | J | 0.00 | 631 | 0 | 1,206 | 575 to 1.2 K (+109.74 %) |
Oct 06 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | J | 0.00 | 32,492 | 0 | 85,775 | 53.3 K to 85.8 K (+60.98 %) |
Oct 06 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 276,000 | 0 | 800,708 | 1.1 M to 800.7 K (-25.63 %) |
Jun 03 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Option Exercise | A | 38.98 | 5,000 | 194,900 | 5,000 | |
Jun 02 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | S | 38.66 | 10,787 | 417,025 | 19,360 | 30.1 K to 19.4 K (-35.78 %) |
May 26 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | J | 0.00 | 53,283 | 0 | 53,283 | 0 to 53.3 K |
May 26 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Sell | J | 0.00 | 600,000 | 0 | 1,076,708 | 1.7 M to 1.1 M (-35.78 %) |
May 10 2004 | PHRM | PHARMION CORP | BLAIR JAMES C | Director | Buy | J | 0.00 | 575 | 0 | 575 | 0 to 575 |
Page: 1